Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Bryon Adinoff

Concepts (373)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
24
2020
133
6.330
 Why?
Alcoholism
22
2023
838
3.470
 Why?
Pituitary-Adrenal System
10
2020
166
2.410
 Why?
Opiate Substitution Treatment
4
2025
198
2.340
 Why?
Hypothalamo-Hypophyseal System
9
2020
201
2.310
 Why?
Brain
15
2025
3009
2.150
 Why?
Substance-Related Disorders
21
2018
1112
2.030
 Why?
Marijuana Use
4
2025
222
2.010
 Why?
Cerebrovascular Circulation
12
2016
293
1.720
 Why?
Opioid-Related Disorders
6
2025
617
1.610
 Why?
Behavior, Addictive
9
2018
89
1.600
 Why?
Methadone
2
2025
131
1.590
 Why?
Amphetamine-Related Disorders
5
2018
53
1.470
 Why?
Tomography, Emission-Computed, Single-Photon
13
2016
104
1.390
 Why?
Sunbathing
3
2018
16
1.330
 Why?
Limbic System
6
2012
55
1.250
 Why?
Hydrocortisone
11
2023
300
1.240
 Why?
Health Services Accessibility
3
2025
1121
1.230
 Why?
Neural Pathways
6
2019
320
1.160
 Why?
Prescription Drug Misuse
2
2019
53
1.050
 Why?
Central Nervous System Stimulants
8
2018
187
1.030
 Why?
Stress, Psychological
4
2020
1174
1.020
 Why?
Adrenocorticotropic Hormone
7
2020
147
1.010
 Why?
Temperance
6
2011
20
1.010
 Why?
Medical Marijuana
2
2019
122
0.990
 Why?
Hippocampus
4
2018
989
0.920
 Why?
Lidocaine
2
2020
55
0.900
 Why?
Procaine
5
2009
10
0.890
 Why?
Frontal Lobe
4
2012
161
0.890
 Why?
Adult
64
2025
41405
0.860
 Why?
Brain Mapping
10
2020
550
0.840
 Why?
Patient Acceptance of Health Care
3
2019
895
0.830
 Why?
Buprenorphine
2
2025
201
0.760
 Why?
Social Stigma
1
2025
177
0.740
 Why?
Humans
101
2025
147293
0.720
 Why?
Health Policy
1
2025
405
0.720
 Why?
Marijuana Smoking
1
2025
249
0.710
 Why?
Cerebral Cortex
8
2020
483
0.690
 Why?
Motivation
5
2019
615
0.670
 Why?
Nerve Net
3
2019
288
0.650
 Why?
Middle Aged
46
2023
36821
0.650
 Why?
Bupropion
2
2019
48
0.640
 Why?
Cues
3
2020
329
0.640
 Why?
Anesthetics, Local
3
2009
104
0.620
 Why?
Memory Consolidation
1
2020
14
0.620
 Why?
Research Design
4
2022
1157
0.620
 Why?
Drug-Seeking Behavior
1
2020
22
0.620
 Why?
Naloxone
2
2016
138
0.620
 Why?
Corticotropin-Releasing Hormone
4
2020
72
0.600
 Why?
Psychological Trauma
1
2020
58
0.590
 Why?
Crime
1
2019
58
0.590
 Why?
Antidepressive Agents, Second-Generation
2
2019
46
0.580
 Why?
Male
63
2023
73950
0.580
 Why?
Corpus Striatum
4
2018
181
0.570
 Why?
Legislation, Drug
1
2019
73
0.570
 Why?
Social Justice
1
2019
82
0.570
 Why?
Psychiatry
1
2022
197
0.560
 Why?
Impulsive Behavior
3
2014
145
0.550
 Why?
Naltrexone
2
2018
115
0.550
 Why?
Recurrence
9
2017
1151
0.540
 Why?
Adrenal Cortex
2
2010
33
0.530
 Why?
Alcohol Deterrents
1
2018
26
0.520
 Why?
Outpatients
3
2017
450
0.520
 Why?
Magnetic Resonance Imaging
13
2020
3980
0.520
 Why?
Alcohol Drinking
5
2023
858
0.520
 Why?
Pituitary Gland
2
2010
149
0.500
 Why?
Temporal Lobe
3
2017
113
0.500
 Why?
Stress Disorders, Post-Traumatic
4
2019
902
0.500
 Why?
Family Conflict
1
2017
43
0.500
 Why?
Drinking Behavior
1
2016
15
0.500
 Why?
Support Vector Machine
1
2016
34
0.490
 Why?
Oxygen
4
2015
998
0.490
 Why?
Methanol
1
2016
44
0.480
 Why?
Analgesics, Opioid
1
2025
1167
0.480
 Why?
Substance Abuse Treatment Centers
4
2014
49
0.480
 Why?
Self Concept
1
2018
259
0.470
 Why?
Optic Nerve Diseases
1
2016
49
0.470
 Why?
Young Adult
20
2025
14437
0.460
 Why?
Marijuana Abuse
1
2019
215
0.460
 Why?
Female
54
2020
80076
0.460
 Why?
Gyrus Cinguli
5
2020
99
0.450
 Why?
Liability, Legal
1
2016
42
0.450
 Why?
Ultraviolet Rays
2
2016
385
0.450
 Why?
Regional Blood Flow
4
2012
514
0.440
 Why?
Mortality
1
2018
382
0.440
 Why?
Case-Control Studies
10
2023
3660
0.430
 Why?
Self-Control
1
2016
56
0.430
 Why?
Dopamine
2
2016
295
0.430
 Why?
Neuroimaging
2
2016
309
0.420
 Why?
Narcotic Antagonists
4
2016
210
0.410
 Why?
Drug Overdose
2
2016
381
0.400
 Why?
Hyperventilation
1
2013
15
0.400
 Why?
Psilocybin
1
2013
5
0.390
 Why?
Human Experimentation
1
2013
12
0.390
 Why?
Glucocorticoids
2
2010
537
0.390
 Why?
Severity of Illness Index
4
2016
2973
0.380
 Why?
Personality
1
2014
131
0.370
 Why?
Confidentiality
1
2013
80
0.370
 Why?
Bipolar Disorder
5
2017
307
0.360
 Why?
Prefrontal Cortex
4
2020
342
0.360
 Why?
Methamphetamine
2
2013
75
0.360
 Why?
Ondansetron
1
2012
20
0.360
 Why?
Serotonin Antagonists
1
2012
32
0.360
 Why?
Cocaine
4
2020
162
0.360
 Why?
Psychomotor Performance
3
2019
326
0.350
 Why?
Algorithms
3
2016
1868
0.350
 Why?
Allostasis
2
2023
17
0.350
 Why?
Neuropeptide Y
1
2011
9
0.350
 Why?
Substance Withdrawal Syndrome
4
2010
185
0.340
 Why?
Hallucinogens
1
2013
112
0.340
 Why?
Intention
1
2012
187
0.320
 Why?
Patient Compliance
4
2013
591
0.320
 Why?
Radiopharmaceuticals
4
2016
210
0.320
 Why?
Decision Making
3
2016
994
0.320
 Why?
Brain-Derived Neurotrophic Factor
1
2011
155
0.310
 Why?
Emotions
1
2016
583
0.310
 Why?
Heart Rate
5
2016
860
0.310
 Why?
Predictive Value of Tests
1
2016
2133
0.310
 Why?
Receptors, Cholinergic
1
2010
42
0.310
 Why?
Double-Blind Method
9
2020
2080
0.310
 Why?
Feedback, Physiological
1
2010
80
0.300
 Why?
Anxiety
2
2020
1149
0.300
 Why?
Rest
2
2015
127
0.290
 Why?
Surveys and Questionnaires
7
2016
6164
0.280
 Why?
Community Health Services
1
2010
231
0.270
 Why?
Blood Pressure
6
2016
1785
0.270
 Why?
Cognition Disorders
1
2012
551
0.260
 Why?
Adrenal Insufficiency
1
2008
31
0.260
 Why?
Disruptive, Impulse Control, and Conduct Disorders
1
2007
9
0.250
 Why?
Acetylcholine
1
2007
209
0.250
 Why?
Occipital Lobe
1
2006
30
0.240
 Why?
United Kingdom
2
2025
391
0.240
 Why?
Functional Neuroimaging
3
2017
62
0.230
 Why?
Portugal
1
2025
10
0.230
 Why?
Russia
1
2025
12
0.230
 Why?
France
1
2025
40
0.230
 Why?
Iran
1
2025
44
0.230
 Why?
Technetium Tc 99m Exametazime
3
2012
4
0.230
 Why?
Cohort Studies
7
2019
6099
0.230
 Why?
Attention Deficit Disorder with Hyperactivity
3
2018
434
0.230
 Why?
United States
8
2025
16313
0.230
 Why?
Neural Inhibition
1
2007
180
0.230
 Why?
Cannabis
2
2025
518
0.220
 Why?
Neuropsychological Tests
3
2016
1145
0.220
 Why?
Australia
1
2025
299
0.210
 Why?
Randomized Controlled Trials as Topic
5
2015
1776
0.210
 Why?
Self Report
4
2018
887
0.210
 Why?
Treatment Outcome
12
2020
11947
0.210
 Why?
Canada
1
2025
435
0.210
 Why?
Attitude to Health
1
2007
431
0.200
 Why?
Personality Inventory
2
2014
134
0.190
 Why?
Smoking Cessation
4
2015
441
0.180
 Why?
Alcoholic Intoxication
1
2003
77
0.180
 Why?
Neostriatum
2
2016
37
0.180
 Why?
Global Health
1
2025
406
0.180
 Why?
Saliva
1
2003
252
0.170
 Why?
Affect
3
2016
323
0.170
 Why?
Executive Function
3
2016
472
0.170
 Why?
Health Behavior
1
2007
799
0.170
 Why?
Kindling, Neurologic
1
2001
2
0.170
 Why?
Smoking
3
2013
1483
0.170
 Why?
Alcohol Withdrawal Delirium
2
2003
9
0.170
 Why?
Models, Neurological
2
2018
253
0.160
 Why?
Magnetic Resonance Angiography
2
2014
251
0.160
 Why?
gamma-Aminobutyric Acid
2
2008
195
0.160
 Why?
Pituitary-Adrenal Function Tests
1
2020
3
0.160
 Why?
Voltage-Gated Sodium Channel Blockers
1
2020
7
0.160
 Why?
Antimanic Agents
2
2017
19
0.160
 Why?
Dexamethasone
2
2005
368
0.160
 Why?
Prazosin
1
2020
25
0.150
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2020
18
0.150
 Why?
Reward
2
2016
248
0.150
 Why?
Family Health
2
2013
195
0.150
 Why?
Anticipation, Psychological
1
2020
20
0.150
 Why?
Amygdala
2
2016
203
0.150
 Why?
Sex Factors
5
2014
2136
0.150
 Why?
Age Factors
2
2025
3372
0.150
 Why?
Psychological Tests
1
2020
131
0.150
 Why?
Psychiatric Status Rating Scales
5
2014
537
0.150
 Why?
Public Policy
1
2019
81
0.150
 Why?
Reproducibility of Results
3
2016
3448
0.140
 Why?
Endophenotypes
1
2018
24
0.140
 Why?
Product Surveillance, Postmarketing
1
2019
74
0.140
 Why?
Harm Reduction
1
2019
49
0.140
 Why?
Emergency Service, Hospital
3
2019
2416
0.130
 Why?
Drug Evaluation, Preclinical
1
2019
196
0.130
 Why?
Narcolepsy
1
2018
25
0.130
 Why?
Alcohol-Related Disorders
2
2013
126
0.130
 Why?
Ethanol
2
2003
634
0.130
 Why?
Adolescent
11
2025
22825
0.130
 Why?
Drug Therapy, Combination
2
2018
1046
0.120
 Why?
Risk Factors
4
2018
11017
0.120
 Why?
Sensitivity and Specificity
3
2016
2017
0.120
 Why?
Choice Behavior
1
2018
181
0.120
 Why?
Dehydroepiandrosterone
1
1996
49
0.120
 Why?
Ultraviolet Therapy
1
2016
17
0.120
 Why?
Exercise Test
2
2016
636
0.120
 Why?
Methylphenidate
2
2015
49
0.120
 Why?
Autonomic Nervous System
1
2016
83
0.120
 Why?
Skin Neoplasms
2
2016
865
0.120
 Why?
Antipsychotic Agents
2
2017
211
0.120
 Why?
Follow-Up Studies
4
2017
5476
0.120
 Why?
Data Interpretation, Statistical
2
2015
369
0.120
 Why?
Animals
6
2020
38410
0.110
 Why?
Erythropoietin
1
2016
100
0.110
 Why?
Cytidine Diphosphate Choline
1
2015
2
0.110
 Why?
Image Processing, Computer-Assisted
3
2012
794
0.110
 Why?
Research
1
2019
434
0.110
 Why?
Receptors, Dopamine D2
1
2016
93
0.110
 Why?
Nootropic Agents
1
2015
30
0.110
 Why?
Cluster Analysis
1
2016
502
0.110
 Why?
Psoriasis
1
2016
115
0.110
 Why?
Population Surveillance
1
2018
486
0.110
 Why?
Computer Graphics
1
2015
41
0.110
 Why?
Parietal Lobe
1
2015
62
0.110
 Why?
Stress, Physiological
1
1998
445
0.110
 Why?
Dibenzothiazepines
1
2014
18
0.100
 Why?
Proportional Hazards Models
1
2018
1344
0.100
 Why?
Residential Treatment
1
2014
30
0.100
 Why?
Anti-Inflammatory Agents
1
1997
481
0.100
 Why?
Functional Laterality
1
2015
241
0.100
 Why?
Menthol
1
2013
11
0.100
 Why?
Cognition
2
2016
1286
0.100
 Why?
Heroin Dependence
1
2014
33
0.100
 Why?
Time Factors
3
2016
7173
0.100
 Why?
Clinical Trials as Topic
1
2019
1072
0.100
 Why?
Drug Users
1
2013
43
0.100
 Why?
Texas
2
2012
278
0.100
 Why?
Self Care
1
2016
395
0.090
 Why?
United States Department of Veterans Affairs
1
2018
793
0.090
 Why?
September 11 Terrorist Attacks
1
2013
31
0.090
 Why?
Prehypertension
1
2012
27
0.090
 Why?
Mexican Americans
1
2014
119
0.090
 Why?
Image Interpretation, Computer-Assisted
1
2015
297
0.090
 Why?
Buspirone
1
2012
5
0.090
 Why?
Serotonin Receptor Agonists
1
2012
27
0.090
 Why?
Parahippocampal Gyrus
1
2012
11
0.090
 Why?
Tobacco Products
1
2013
90
0.090
 Why?
Carrier Proteins
1
1996
731
0.090
 Why?
Receptors, Serotonin, 5-HT3
1
2012
16
0.090
 Why?
Retrospective Studies
3
2018
17560
0.090
 Why?
Recovery of Function
1
2016
724
0.090
 Why?
Spin Labels
1
2011
60
0.090
 Why?
Conditioning, Classical
1
2012
120
0.090
 Why?
Reference Values
2
2003
800
0.090
 Why?
Photic Stimulation
1
2012
266
0.090
 Why?
Sodium Chloride
1
2012
138
0.080
 Why?
Subthalamic Nucleus
1
2012
85
0.080
 Why?
Life Change Events
2
2013
149
0.080
 Why?
Speech
1
2011
76
0.080
 Why?
Analysis of Variance
2
2003
1302
0.080
 Why?
Health Status
1
2016
839
0.080
 Why?
Secondary Prevention
1
2012
253
0.080
 Why?
Anti-Anxiety Agents
1
2010
48
0.080
 Why?
Physostigmine
1
2010
13
0.080
 Why?
Age of Onset
1
2012
568
0.080
 Why?
Cholinergic Antagonists
1
2010
24
0.080
 Why?
Cholinesterase Inhibitors
1
2010
47
0.080
 Why?
Depressive Disorder
1
2012
379
0.070
 Why?
Propensity Score
3
2016
379
0.070
 Why?
Tobacco Use Disorder
1
2011
217
0.070
 Why?
Conduct Disorder
1
2011
158
0.070
 Why?
Survivors
1
2013
528
0.070
 Why?
Factor Analysis, Statistical
1
2010
296
0.070
 Why?
Statistics, Nonparametric
1
2010
430
0.070
 Why?
Exercise
3
2016
2219
0.070
 Why?
Dopamine Plasma Membrane Transport Proteins
1
2009
59
0.070
 Why?
Memory
2
2010
300
0.070
 Why?
Nicotine
1
2011
336
0.070
 Why?
Adrenal Cortex Function Tests
1
2008
1
0.070
 Why?
Receptors, Cannabinoid
1
2008
13
0.070
 Why?
Depression
1
2018
1599
0.070
 Why?
Chronic Disease
1
2014
1844
0.070
 Why?
Parasympathetic Nervous System
1
2007
26
0.070
 Why?
Automatism
1
2007
1
0.060
 Why?
Cross-Sectional Studies
5
2016
6011
0.060
 Why?
Quetiapine Fumarate
2
2017
26
0.060
 Why?
Mass Screening
2
2012
1375
0.060
 Why?
Adaptation, Psychological
2
2011
736
0.060
 Why?
Psychometrics
1
2010
739
0.060
 Why?
Prognosis
1
2015
4383
0.060
 Why?
Receptors, N-Methyl-D-Aspartate
1
2008
233
0.060
 Why?
Serotonin
1
2008
300
0.060
 Why?
Cortodoxone
1
2005
1
0.060
 Why?
Endorphins
1
2005
9
0.060
 Why?
Diagnosis, Dual (Psychiatry)
3
2014
40
0.060
 Why?
Cosyntropin
1
2005
7
0.060
 Why?
Blood Flow Velocity
1
2006
422
0.050
 Why?
Prevalence
2
2013
2889
0.050
 Why?
Aged
4
2018
26514
0.050
 Why?
Demography
1
2005
283
0.050
 Why?
Comorbidity
4
2017
1672
0.050
 Why?
Obesity
1
2018
3149
0.050
 Why?
Mathematical Computing
1
2003
11
0.050
 Why?
Gambling
1
2003
29
0.050
 Why?
Linear Models
2
2016
852
0.050
 Why?
Breath Tests
1
2003
77
0.050
 Why?
Nucleus Accumbens
1
2004
136
0.050
 Why?
Learning
1
2007
446
0.050
 Why?
Dominance, Cerebral
1
2003
58
0.050
 Why?
Single-Blind Method
1
2003
319
0.050
 Why?
Sheep
1
2005
879
0.040
 Why?
Infusions, Intravenous
1
2003
430
0.040
 Why?
Adrenal Cortex Hormones
1
2005
487
0.040
 Why?
Patient Admission
1
2003
220
0.040
 Why?
Mental Disorders
1
2010
1188
0.040
 Why?
Residence Characteristics
2
2015
387
0.040
 Why?
National Institute on Drug Abuse (U.S.)
2
2011
3
0.040
 Why?
C-Reactive Protein
1
2023
430
0.040
 Why?
Placebos
1
2001
193
0.040
 Why?
Uncertainty
1
2020
146
0.040
 Why?
Genetic Predisposition to Disease
1
2008
2458
0.040
 Why?
Dose-Response Relationship, Drug
1
2002
2030
0.030
 Why?
Child
2
2016
22979
0.030
 Why?
Organ Size
1
2018
465
0.030
 Why?
Valproic Acid
1
2017
49
0.030
 Why?
Diazepam Binding Inhibitor
1
1996
2
0.030
 Why?
Disease Models, Animal
1
2007
4604
0.030
 Why?
Heliotherapy
1
2016
1
0.030
 Why?
Tanning
1
2016
1
0.030
 Why?
Liver Function Tests
1
1995
105
0.030
 Why?
Neurologic Examination
1
1995
132
0.030
 Why?
Nutrition Surveys
1
2016
279
0.030
 Why?
Blood-Brain Barrier
1
1995
166
0.030
 Why?
Signal Processing, Computer-Assisted
1
2015
153
0.030
 Why?
Craving
1
2014
42
0.030
 Why?
Basal Metabolism
1
2014
59
0.030
 Why?
Automation
1
2014
104
0.030
 Why?
Delayed-Action Preparations
1
2014
191
0.020
 Why?
New York City
1
2013
87
0.020
 Why?
Mexico
1
2014
233
0.020
 Why?
Self Administration
1
2013
122
0.020
 Why?
Aged, 80 and over
2
2018
8430
0.020
 Why?
Stroop Test
1
2013
24
0.020
 Why?
Blood Circulation Time
1
2011
3
0.020
 Why?
Disasters
1
2013
104
0.020
 Why?
Motivational Interviewing
1
2013
122
0.020
 Why?
Psychotherapy, Brief
1
2011
41
0.020
 Why?
Models, Statistical
1
2015
677
0.020
 Why?
Clinical Protocols
1
2012
284
0.020
 Why?
Informed Consent
1
2012
200
0.020
 Why?
Combat Disorders
1
2010
42
0.020
 Why?
Multicenter Studies as Topic
1
2012
417
0.020
 Why?
Aftercare
1
2012
225
0.020
 Why?
Nicotinic Agonists
1
2011
135
0.020
 Why?
Rats
1
2018
5613
0.020
 Why?
Risk-Taking
1
2012
325
0.020
 Why?
Family
1
2014
690
0.020
 Why?
Body Weight
1
2012
976
0.020
 Why?
Contrast Media
1
2011
500
0.020
 Why?
Longitudinal Studies
1
2016
3027
0.020
 Why?
Nerve Fibers, Myelinated
1
2008
48
0.020
 Why?
Socioeconomic Factors
1
2012
1342
0.020
 Why?
Medication Adherence
1
2012
540
0.020
 Why?
Pregnancy Complications
1
2013
606
0.020
 Why?
Logistic Models
1
2012
2142
0.020
 Why?
Regression Analysis
1
2009
1003
0.020
 Why?
Biomarkers
1
2018
4351
0.020
 Why?
Hypothalamus
1
2008
164
0.020
 Why?
Risk Assessment
1
2016
3784
0.010
 Why?
Incidence
1
2013
2954
0.010
 Why?
Survival Analysis
1
2009
1386
0.010
 Why?
Referral and Consultation
1
2012
886
0.010
 Why?
Peer Group
1
2008
258
0.010
 Why?
Synapses
1
2008
448
0.010
 Why?
Pilot Projects
1
2009
1912
0.010
 Why?
Military Personnel
1
2010
749
0.010
 Why?
Pregnancy
1
2013
7274
0.010
 Why?
Diagnostic Errors
1
2001
182
0.010
 Why?
Quality of Life
1
2012
3246
0.010
 Why?
Prospective Studies
1
2011
8164
0.010
 Why?
Carbamazepine
1
1995
24
0.010
 Why?
Psychoses, Substance-Induced
1
1995
16
0.010
 Why?
Adinoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (2) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)